BRIEF published on 07/11/2025 at 20:26, 4 months 24 days ago Brenntag SE Adjusts 2025 Financial Forecast Amid Market Challenges Financial Results Market Challenges Forecast Adjustment Exchange Rates Earning Guidance
PRESS RELEASE published on 07/11/2025 at 20:21, 4 months 24 days ago EQS-Adhoc: Brenntag SE publishes preliminary results for the second quarter of 2025 and adjusts its guidance for the financial year 2025 Brenntag SE adjusts forecast for 2025 due to adverse exchange rates and economic uncertainties, expecting EUR 950-1,050 million operating EBITA Forecast Adjustment 2025 Exchange Rates Economic Uncertainties Brenntag SE
BRIEF published on 05/21/2025 at 09:19, 6 months 14 days ago Jens Birgersson Appointed as New CEO of Brenntag SE CEO Appointment Leadership Change Brenntag SE Chemical Distribution Jens Birgersson
PRESS RELEASE published on 05/21/2025 at 09:14, 6 months 14 days ago EQS-Adhoc: Brenntag SE: Jens Birgersson to become new CEO Brenntag SE appoints Jens Birgersson as new CEO, succeeding Dr. Christian Kohlpaintner. Birgersson brings international management experience from ROCKWOOL Group CEO Appointment Management Board Brenntag SE Jens Birgersson Rockwool Group
BRIEF published on 11/26/2024 at 12:22, 1 year ago Brenntag CEO Dr. Christian Kohlpaintner to Depart by 2025 Succession Planning CEO Change Brenntag Christian Kohlpaintner Chemical Distribution
PRESS RELEASE published on 11/26/2024 at 12:17, 1 year ago EQS-Adhoc: Brenntag CEO Dr. Christian Kohlpaintner will not extend his contract beyond 2025 Brenntag CEO Dr. Christian Kohlpaintner will not extend his contract beyond 2025. Supervisory Board initiating CEO succession process Contract Extension CEO Succession Process Brenntag Christian Kohlpaintner
BRIEF published on 08/12/2024 at 21:44, 1 year 3 months ago Brenntag SE Adjusts Financial Guidance for 2024 Half-year Report Financial Guidance Market Trends Operating EBITA Chemical Industry
PRESS RELEASE published on 08/12/2024 at 21:39, 1 year 3 months ago EQS-Adhoc: Brenntag SE adjusts guidance for the financial year 2024 Brenntag SE adjusts guidance, lowers operating EBITA forecast for FY 2024 due to challenging market environment impacting profit per unit development and volume growth expectations Forecast Adjustment Financial Year 2024 Operating EBITA Guidance Brenntag SE
PRESS RELEASE published on 03/07/2023 at 18:49, 2 years 8 months ago EQS-Adhoc: Brenntag SE resolves on share buyback program with a total volume of up to EUR 750 million
PRESS RELEASE published on 01/02/2023 at 21:35, 2 years 11 months ago EQS-Adhoc: Brenntag SE terminates preliminary discussions with Univar Solutions Inc.
Published on 12/05/2025 at 02:35, 2 hours 49 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 24 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 19 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 24 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 54 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 33 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 59 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 9 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 13 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 24 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 39 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 40 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 23 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025
